Notice of Intent to Sole Source the Procurement of Weekly Delivery of Turkey, Chicken, Guinea Pig, and Horse Red Blood Cells

The Centers for Disease Control and Prevention (CDC) intends to award a sole-source contract for the weekly delivery of turkey, chicken, guinea pig, and horse red blood cells (RBCs) for use in hemagglutination inhibition (HI) assays. The required RBCs must be produced using manufacturing, donor sourcing, collection, processing, quality control, and storage practices that yield consistent hemagglutination performance across all required animal species. The products must demonstrate compatibility with the Influenza Division's validated assay protocols and preserve comparability with historical antigenic characterization data used for routine influenza surveillance. • The contract is for a firm fixed price. • The RBCs must be manufactured by Lampire Biological Laboratories. • The products must demonstrate compatibility with the Influenza Division's validated assay protocols. • The contract is for weekly delivery of RBCs. • The products must preserve comparability with historical antigenic characterization data used for routine influenza surveillance.